aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference

Core Insights - aTyr Pharma, Inc. is a clinical stage biotechnology company focused on developing first-in-class medicines from its proprietary tRNA synthetase platform [1][3] - The company will present at the Piper Sandler 37 Annual Healthcare Conference on December 2, 2025, in New York, NY [1][2] Company Overview - aTyr leverages evolutionary intelligence to translate tRNA synthetase biology into new therapies targeting fibrosis and inflammation [3] - The company's lead therapeutic candidate, efzofitimod, is an immunomodulator in clinical development for treating interstitial lung disease, which involves immune-mediated disorders causing lung inflammation and progressive fibrosis [3]